Study | Total Patients (n) | Patients with AF (n) | Gender | Age (y) | Follow up (y) | References |
---|---|---|---|---|---|---|
Study 1 | 2236 | 2236 | 78.3% (male) | 74.3 ± 8.3 | 2.0-3.7 | Yasuda et al., 2019 [3] |
Study 2 | 4614 | 4614 | Random | 54 ± 5 | > 1 | Lopes et al., 2019 [6] |
Study 3 | 1403 | 1403 | Random | 74 | 1.0–2.0 | Popma et al., 2019 [8] |
Study 4 | 24,711 | 13,952 | 59.5% (male) | > 18 | 1 | Gialdini et al., 2014 [22] |
Study 5 | 150 | 150 | 60% (male) | 52 ± 8.2 | 0.5–1.4 | Wang et al., 2015 [33] |
Study 6 | 69,202 | 69,202 | 56% (male) | 45 ± 19.5 | > 1 | Kaatz et al., 2010 [32] |
Study 7 | 26,046 | 26,046 | 51% (male) | ≥ 67 | 1.3 to 1.5 | Koshy et al., 2019 [9] |
Study 8 | 3068 | 3068 | 53%(male) | 18< | > 1 | Lotfi et al., 2011 [12] |
Study 9 | 382 | 382 | male 73.3% | ≥ 70 | > 1 | Barbieri et al., 2013 [24] |
Study 10 | 161 | 161 | males (77%) | 72 | 8.5 | Konstantino et al., 2016 [1] |
Study 11 | 7145 | 2183 | males (79%) | 68.9 ± 7.7 | 9.8 | Thorén et al., 2020 [14] |
Study 12 | 186 | 186 | male 63.3% | ≥ 75 | 1 | Ye et al., 2022 [31] |
Study 13 | 1014 | 1014 | males (57%) | 75 ± 8 | 2 | Kefer et al., 2015 [2] |
Study 14 | 3474 | 3474 | males (59%) | 63 ± 7.3 | > 1 | Işık et al., 2021 [25] |
Study 15 | 4060 | 4060 | males (71.5%) | ≥ 65 | 3.5 ± 1.3 | Qureshi et al., 2016 [13] |
Study 16 | 77 | 77 | males (59%) | > 65 | 0.5–1.6 | Healey et al., 2005 [7] |